0001193805-15-000826.txt : 20150529 0001193805-15-000826.hdr.sgml : 20150529 20150529145958 ACCESSION NUMBER: 0001193805-15-000826 CONFORMED SUBMISSION TYPE: NT 10-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150228 FILED AS OF DATE: 20150529 DATE AS OF CHANGE: 20150529 EFFECTIVENESS DATE: 20150529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAGNA LAB INC CENTRAL INDEX KEY: 0000895464 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 113074326 STATE OF INCORPORATION: NY FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: NT 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21320 FILM NUMBER: 15898982 BUSINESS ADDRESS: STREET 1: 6800 JERICHO TURNPIKE, SUITE 120W CITY: SYOSSET STATE: NY ZIP: 11791 BUSINESS PHONE: (516) 393 5874 MAIL ADDRESS: STREET 1: 6800 JERICHO TURNPIKE, SUITE 120W CITY: SYOSSET STATE: NY ZIP: 11791 NT 10-K 1 e613720_nt10k-magna.htm Unassociated Document
Form 12b-25. - NOTIFICATION OF LATE FILING
FORM 12b-25
 
 
SEC FILE NUMBER
0-21320
     
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
(Check One):  x  Form 10-K  o Form 20-F  o Form 11-K   o Form 10-Q o Form N-SAR
 
   For Period Ended:  February 28, 2015                                
   o        Transition Report on Form 10-K
   o        Transition Report on Form 20-F
   o        Transition Report on Form 11-K
   o        Transition Report on Form 10-Q
   o        Transition Report on Form N-SAR
 
For the Transition Period Ended:  
 
Read Instruction (on back page)  Before Preparing Form.  Please Print or Type.
Nothing in this form shall be construed to imply that the Commissions has
verified any information contained herein.
  
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
 
 
PART I -REGISTRANT INFORMATION

Magna-Lab Inc.
Full Name of Registrant:
 
Former Name if Applicable
 
Address of Principal Executive Office (Street and Number)
 
6800 Jericho Turnpike, Suite 120W Syosset, New York  11791
City, State and Zip Code
 
PART II - Rules 12b.25(b) AND 9c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.
(Check box if appropriate)
 
 
x
(a)  The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
 
 
x
(b)  The subject annual report, semi-annual report, transition report on Form 10- K, Form 20-F, ll-K, Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date;
 
 
 
(c)  The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
      
 
 
 
 
PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach Extra Sheets if Needed):

Additional time is needed to complete the preparation and audit of the annual report for the year ended February 28, 2015 due to limitations caused by the Company’s very limited resources.

PART IV - OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this notification
 
Kenneth C. Riscica
516
869 8265
(Name) (Area Code) (Telephone Number)
 
(2)  Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s).                  x Yes         o No
 
(3)  Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statement to be included in the subject report or portion thereof?   No.

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
Magna-Lab Inc.  
(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 29, 2015                                                      

By /s/ Kenneth C. Riscica, Treasurer and Secretary (principal financial officer)

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001)